Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE Mateos, MV, Dimopoulos, MA, Cavo, M, Suzuki, K, Knop, S, Doyen, C, Lucio, P, Nagy, Z, Pour, L, Grosicki, S, Crepaldi, A, Liberati, AM, Campbell, Philip, Yoon, SS, Iosava, G, Fujisaki, T, Garg, M, Iida, S, Bladé, J, Ukropec, J, Pei, H, Van Rampelbergh, R, Kudva, A, Qi, M and San-Miguel, J 2021, Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE, Clinical Lymphoma, Myeloma and Leukemia, vol. 21, no. 11, pp. 785-798, doi: 10.1016/j.clml.2021.06.005. Attached Files Name Description MIMEType Size Downloads Title Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE Author(s) Mateos, MV Dimopoulos, MA Cavo, M Suzuki, K Knop, S Doyen, C Lucio, P Nagy, Z Pour, L Grosicki, S Crepaldi, A Liberati, AM Campbell, Philip Yoon, SS Iosava, G Fujisaki, T Garg, M Iida, S Bladé, J Ukropec, J Pei, H Van Rampelbergh, R Kudva, A Qi, M San-Miguel, J Journal name Clinical Lymphoma, Myeloma and Leukemia Volume number 21 Issue number 11 Start page 785 End page 798 Total pages 14 Publisher Elsevier Place of publication Amsterdam, The Netherlands Publication date 2021-11 ISSN 2152-2650 2152-2669 Keyword(s) CD38 Clinical study Efficacy Frail Monoclonal antibody Language eng DOI 10.1016/j.clml.2021.06.005 Field of Research 1103 Clinical Sciences 1112 Oncology and Carcinogenesis HERDC Research category C1 Refereed article in a scholarly journal Free to Read? Yes Persistent URL http://hdl.handle.net/10536/DRO/DU:30159548 Document type: Journal Article Collections: Faculty of Health School of Medicine Open Access Collection Related Links Link Description Link to full-text (open access)   Connect to published version Go to link with your DU access privileges   Connect to Elements publication management system Go to link with your DU access privileges     Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved. Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au. Versions Version Filter Type Mon, 29 Nov 2021, 09:08:27 EST Mon, 29 Nov 2021, 15:04:19 EST Wed, 15 Dec 2021, 05:05:16 EST Thu, 17 Feb 2022, 08:33:57 EST Thu, 17 Feb 2022, 14:39:13 EST Thu, 17 Feb 2022, 14:44:15 EST Thu, 17 Feb 2022, 14:56:35 EST Sat, 12 Mar 2022, 16:35:17 EST Filtered Full Citation counts:   Cited 3 times in TR Web of Science Cited 2 times in Scopus Search Google Scholar Access Statistics: 15 Abstract Views, 0 File Downloads  -  Detailed Statistics Created: Mon, 29 Nov 2021, 09:08:27 EST